PCNA is used to examine epidermal hyperproliferation in psoriasis and the potential for malignancy in skin lesions, and CCD1 is a key regulator of cell cycle progression in psoriasis, and both are downstream of the Wnt5a/β-catenin pathway genes (Castilla et al., 2012). This evidence concerns the gene WNT5A and psoriasis.